Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA261638
Max Phase: Preclinical
Molecular Formula: C23H21ClN2O2
Molecular Weight: 392.89
Molecule Type: Small molecule
Associated Items:
ID: ALA261638
Max Phase: Preclinical
Molecular Formula: C23H21ClN2O2
Molecular Weight: 392.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=c1cc(OCCCn2ccc3ccccc32)ccn1Cc1ccccc1Cl
Standard InChI: InChI=1S/C23H21ClN2O2/c24-21-8-3-1-7-19(21)17-26-14-11-20(16-23(26)27)28-15-5-12-25-13-10-18-6-2-4-9-22(18)25/h1-4,6-11,13-14,16H,5,12,15,17H2
Standard InChI Key: VHZJTPXVMGCZDY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 392.89 | Molecular Weight (Monoisotopic): 392.1292 | AlogP: 4.97 | #Rotatable Bonds: 7 |
Polar Surface Area: 36.16 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.47 | CX LogD: 4.47 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.42 | Np Likeness Score: -1.56 |
1. Tipparaju SK, Joyasawal S, Forrester S, Mulhearn DC, Pegan S, Johnson ME, Mesecar AD, Kozikowski AP.. (2008) Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase., 18 (12): [PMID:18499454] [10.1016/j.bmcl.2008.05.004] |
Source(1):